When is proton pump inhibitor use appropriate?

Rena Yadlapati, Peter J. Kahrilas*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

43 Scopus citations

Abstract

Proton pump inhibitor (PPI) therapy is commonly used outside of Food and Drug Administration indication for a broad range of conditions such as extra-esophageal reflux and PPI-responsive esophageal eosinophilia. While this may be appropriate in some scenarios, it has also resulted in widespread inappropriate PPI use. At the same time, data suggesting adverse effects of long-term PPI therapy are multiplying, albeit mainly from low quality studies. The systematic review by Scarpignato et al. (BMC Med 14:179, 2016) addresses this dilemma with a comprehensive analysis of the risks and benefits of PPI use. The authors concluded that, while PPIs are highly efficacious in erosive acid-peptic disorders, efficacy is not equaled in other conditions. In some instances, they found no supportive evidence of benefit. With respect to side effects, they indicated that the questionable harms associated with PPI therapy do not outweigh the benefits afforded by appropriate PPI use. However, inappropriate PPI use results in increased healthcare costs and unnecessary exposure to potential adverse effects. Ideally, PPI therapy should be personalized, based on indication, effectiveness, patient preference, and risk assessment. Please see related article: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0718-z.

Original languageEnglish (US)
Article number36
JournalBMC Medicine
Volume15
Issue number1
DOIs
StatePublished - Feb 21 2017

Keywords

  • Gastroesophageal reflux disease
  • Indication
  • Proton pump inhibitors

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'When is proton pump inhibitor use appropriate?'. Together they form a unique fingerprint.

Cite this